Avita Medical Inc (RCEL)

Cost of Revenue

$13.95M

TTM · Period ending: · USD

RCEL logo

RCEL Cost of Revenue

Latest reported$13.95M
RCEL TTM Cost of Revenue ($747.87K → $13.95M)
High-resolution chart · PNG

RCEL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Avita Medical Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
13,950,000
13,484,000
12,794,000
11,769,000
11,772,000
10,414,000
9,094,000
8,610,000
7,533,000
7,626,000
7,780,000
7,331,000
6,748,000
5,930,000
6,041,000
5,511,000
5,069,000
5,736,000
6,104,000
6,108,000
5,949,000
4,770,000
3,668,018
4,048,180
4,481,105
4,226,502
3,792,542
2,851,362
1,774,601
1,506,727
1,020,175
894,491
741,563
529,270
544,443
524,379
506,143
463,243
421,432
411,360
401,529
382,713
362,690
323,233
286,997
375,288
463,964
551,839
653,073
645,162
638,655
666,057
668,710
711,493
747,872
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.